Idiopathic Gastroparesis Study
This is a 18-Week Study in Omaha, Nebraska
The purpose of this study is to learn if the study drug, CIN-102, reduces GI symptoms related to idiopathic gastroparesis. If you have idiopathic gastroparesis or are experiencing gastrointestinal symptoms such as nausea, vomiting, bloating, feeling full quickly after eating, and abdominal pain you may qualify for this research study. Qualified participants can receive a free diagnosis and up to $1,100 compensation for their efforts in our study.
Commonly Asked Questions About This Study
Why should I participate in this study?
People choose to participate in clinical trials for a variety of reasons, including receiving compensation for their efforts, no-cost medical exams, the chance to play a more active role in their own health care, gain access to new medical treatments before they are available to the wider public, and help others by contributing to the future of medical science.
Are clinical studies safe?
There are plenty of misconceptions about what happens on a clinical research study. These are just that: myths. Your safety is our number one priority. Drug development is highly regulated with strict safety and ethical guidelines and we take those regulations very seriously. Your health is constantly monitored by specialized physicians with several years of experience.
Do I have to pay to participate in clinical studies?
Participating in our studies won’t cost you a dime. In fact, we compensate you for your efforts during the clinical trial. Our research staff also provides all study-related medication and care at no expense to you.
What if I change my mind about participating?
Our clinical studies are always voluntary. You are free to withdraw your consent at any time. Once you’ve already started the clinical study, our doctors may need you to come back for a visit, just to check that the drug is out of your system.